Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
What does the future of pharma look like? At Reuters Pharma 2025, we will explore how the pharmaceutical industry is evolving and how we can embrace these changes. Meet our team: Nataliya Andreychuk, Co-Founder & CEO; Jean-Francois Delas, Chief Customer Experience Officer; and Roman Kuzminskyi, Chief Business Development Officer—who will be actively participating in discussions […]
At CPHI Japan 2025, meet the Viseven team: Ethan Greely, Account Executive; Ryota Hirano, Portfolio Customer Success Manager; Olena Volkova, Regional Director; and Inyong Lee, Senior Account Manager. Find us at booth #4V-15—stop by for a quick chat! Join us in Tokyo, Japan, at the CPHI Conference, where over 800 pharmaceutical suppliers worldwide will discuss […]
Artificial intelligence is a topic that gets hotter every year. To stay in sync with the industry, the Viseven team—Oleksandra Yashyna, Senior Digital Transformation Manager, Roman Vasylenko, Chief Technology Officer, and Roman Kuzminskyi, Chief Business Development Officer—is heading to Barcelona, Spain, to attend the Pharma Meets AI event. There, pharmaceutical leaders will share insights and […]
It Is Time to Reshape Customer Experience in Pharma. This year, Viseven is bringing a talented team to the summit: We ensure you leave with practical insights drawn from Viseven’s extensive experience in pharma marketing. Do not miss Daniel Atieh’s session, “Less Content, More Value: How AI Shifts Gears in the Attention Race,” where he […]
Our team – Tara DeBellis (Director of Strategy, US) and Leonardo Sanchez (Account Director) – is heading to Philadelphia, USA, for the biggest cross-functional gathering in North America. Held at the Pennsylvania Convention Center, this event is all about advancing pharma marketing and patient engagement. This year, every speaker is committed to delivering at least […]
See Viseven at the Future Pharma Roundtable on AI and Content Automation The Viseven team will once again join the industry leaders at the Future Pharma conference in Boston. Prasant Vijayakumar, Viseven’s Head of Content Strategy and Enablement, will participate in a roundtable on the future of pharma marketing in light of the recent advancements […]
Connect with us at Collision 2024 Viseven’s Chief Brand and Communications Officer, Yuliya Sotska, and Chief Growth Officer, Yaroslava Upatova, will be attending the Collision conference in Toronto on June 17-20, 2024. Viseven will be there for the third consecutive year, and this year Yuliya Sotska will once again be on stage as presenter and moderator. […]
“Are you unbiased?” It’s a fair question after reading a title like this. The honest answer is not completely. We built eWizard, an AI-powered content supply chain platform, so we naturally have firsthand experience with the challenges pharma teams face and the capabilities that help solve them. That said, this article is not intended to […]
A groundbreaking drug is ready to change lives, but regulatory hurdles, soaring R&D costs, and pricing pressures stand in the way of its success. For the pharmaceutical industry, this scenario is the reality of 2026. With a global talent shortage, aging populations driving up healthcare demands, and supply chains still recovering from recent and ongoing […]
For years, pharma influence was relatively easy to recognize. It lived in congress halls, advisory boards, journal publications, and the voices of respected clinical experts. If a physician, researcher, or professor shaped how others understood a therapy area, they were likely part of the KOL conversation. That model still matters. But it no longer covers […]
